Inotuzumab ozogamicin combined with chemotherapy in pediatric B-cell precursor CD22+ acute lymphoblastic leukemia: results of the phase IB ITCC-059 trial.
Pennesi E, Brivio E, Ammerlaan ACJ, Jiang Y, Van der Velden VHJ, Beverloo HB, Sleight B, Locatelli F, Brethon B, Rossig C, Engstler G, Nilsson A, Bruno B, Petit A, Bielorai B, Rizzari C, Rialland F, Rubio-San-Simón A, Sirvent FJB, Diaz-de-Heredia C, Rives S, Zwaan CM.
Pennesi E, et al. Among authors: rives s.
Haematologica. 2024 Oct 1;109(10):3157-3166. doi: 10.3324/haematol.2023.284409.
Haematologica. 2024.
PMID: 38186333
Free PMC article.
Clinical Trial.